Skip to content
thestock.space

On 6 Nov 2026, Advanced Enzyme Technologies was priced at ₹280.30, or 18.4× trailing earnings, against an industry P/E of 22.1×, and the shares are 33% below their 52-week high. Its ROCE of 14% is the second-lowest among the 7 largest Specialty Chemicals peers, and sales and net profit grew 11% and 17% a year over 3 years. It has almost no debt, and its dividend yield is 0.5%. It is a small-cap company with a market cap of ₹3,023 Cr, ranked 46th of 204 Specialty Chemicals companies by market cap; the shares fell 9.4% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹284.30
Day high
₹284.70
Day low
₹278.25
Prev. close
₹284.30
Volume
2.4 L

Health check

2 good · 1 fair · 3 to check
  • ReturnsBehind

    −9.4% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 18.4 vs industry 22.1.

  • GrowthSteady

    Sales +11.3%, profit +16.9% a year over 3 years.

  • ProfitabilityWeak

    ROCE 13.6% vs peer median 24.4%.

  • Balance sheetSolid

    Practically debt-free, Piotroski 7 of 9.

  • Red flags1 to check

    33% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹3,023 Cr, #46 of 204 in its industry by size.

Defensive

Beta 0.68 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹782 Cr · profit ₹171 Cr
Market cap
₹3,023 Cr
Small cap
P/E
18.4
Industry 22.1
Price to book
1.87
Peers 13.33
Dividend yield
0.48%
ROE
11.0%
Peers 23.0%
ROCE
13.6%
Peers 24.4%
Debt to equity
0.03
Debt ₹54 Cr
EPS (TTM)
₹15.25
Face value ₹2
OPM (TTM)
30.2%
Net margin 21.9%
Sales growth
+16.2%
Latest quarter vs a year ago
Profit growth
+11.5%
Latest quarter vs a year ago
Price to sales
3.87
EV/EBITDA 11.3

Strengths and risks

Strengths

  • Practically debt-free.
  • Quarterly sales up 16.2% on a year ago.
  • Net margin of 21.9%.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • 33% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Advanced Enzyme Technologies

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also…

Headquarters
Thane
Employees
409
Sector
Basic Materials
ISIN
INE837H01020
Website
advancedenzymes.com

Price range

52 weeks

₹246.80₹419.00

Today

₹278.25₹284.70
Avg volume (3M)
2.5 L
1-year return
minus 9.4%
From 52-week high
minus 33.1%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
ADVENZYMESAdvanced Enzyme Technologies280.30minus 1.41%3,02318.410.113.6%29.8%0.0311.3%minus 9.4%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
185172203190215
124123140139142
60.149.463.25172.1
32.5%28.7%31.1%26.9%33.6%
10.38.57.2138.7
0.70.60.60.61.2
10.110.210.29.910.9
–11.20.1––
59.558.359.853.568.8
24.9%25.9%24.3%27.9%25.6%
43.342.54337.148.3
3.873.793.843.314.32

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+11.3%
Profit CAGR 3Y
+16.9%
EPS CAGR 3Y
+16.8%
ROE
11.0%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
540623637745
–+15.4%+2.1%+17.0%
367415439513
173208197232
32.1%33.4%31.0%31.2%
13.726.825.826.4
2.42.93.62.6
3535.236.640.1
−9.2−8.94.516.7
140188187233
26.0%27.1%28.5%25.3%
106133131169
–+26.2%minus 1.6%+28.7%
9.4511.9211.7115.06

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
22.422.422.422.4
1,2131,3021,3981,610
33.547.339.432
153164161175
1,4221,5351,6211,839
289307315327
15.630.721.751.2
0.20.25.65.1
484548595707
633649684748
1,4221,5351,6211,839

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
140141142157
−298−64.6−89.1−74.1
−25.8−59.2−72.5−70.4
−18417.5−19.112.3
−38.2−47.3−34.8−52.4
10294.1108104
−12.5−56.7−59−59.8

Shareholding pattern

Source: NSE filings
43.6%
promoters
  • Promoters43.56%
  • Public56.44%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202643.56%56.44%plus 0.32
30 Jun 202643.24%56.76%minus 0.02
31 Mar 202643.26%56.74%plus 0.22
31 Dec 202543.04%56.96%minus 0.03
30 Sep 202543.07%56.93%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you